Your Cell and Gene Therapy Influencer Type is:
The Incubator
As an Incubator, you are a cultivator of progress through precise actions. You can bring stability and order to complexity and disruption — a skill that is highly desirable in the world of cell and gene therapy. You’re likely a thoughtful pragmatist who excels at minimizing risk. Implementation is your specialty. You like status checkpoints and data, and your work is often fundamental to ensuring decisions are well thought out before they are applied in practice.
Your influence superpower comes from …
An affinity for all things careful and thorough. When you speak, people listen. Why? Because they know you have given your opinions serious consideration. You don’t promote or pursue ideas that haven’t been well researched.
How to use it:
Your structure and self-discipline really shine in an evidence-based industry like ours, where results — successful therapies for patients — are ultimately all that really matters. With your ability to reassess and revise until an action plan perfectly aligns with priorities and risks are mitigated, you allow others to stay grounded and focused.
Watch out for:
Your cautious nature may make you less flexible and slower to make decisions or offer solutions than others are comfortable with, so consider ways to reassure them as you move through decision stages.
Join us at the ISCT 2023 Annual Meeting to get your badge!
May 31 – June 2 | Booth #01
Visit with our experts at Booth #01 and join us for:
Wednesday | May 31
09:15 to 10:15
Room 252A
Featured ISCT Roundtable – Bioprocessing & Manufacturing
The Sources of Variability in Apheresis and Standardizing Collections for Improved Starting Material and Patient Experiences
Learn from the specific perspectives of a hospital, a cell manufacturer, and a device manufacturer about how processes can be optimized and standardized in an apheresis center to achieve better starting raw material and improve the process efficiency.
Thursday | June 1
12:45 to 13:45
Salle Maillot Room
Featured Corporate Session – Science & Innovation Plenary Track
Streamlining Process Optimization From Process Development to Commercial With Automated Solutions
Process automation is vital for any therapeutic provider moving toward commercial manufacturing. With an increasing number of technologies coming to market and new insights being gained, are we truly ready to set industry standards or should we focus on developing guidelines? Join us as we explore this topic and gain insights from thought leaders regarding making platform changes from manual or other automation platforms to take advantage of key technologies on the market, including addressing opportunities and challenges for scale-up and scale-out. Lunch will be provided.
Friday | June 2
08:00 to 9:00
Salle Maillot Room
Featured Corporate Session – First in Human to Clinical Acceleration Track
Improve Your Starting Material and the Patient Experience With Data and Partnering
Join us for a patient-first discussion among thought leaders about how the industry can influence the quality of their starting material and why this is important in the delivery and development of cell and gene therapies. Coffee and light pastries will be provided.
Be sure to register to save your spot and reserve your headset for the live demos.
Thursday | June 1
10:30
Booth #01
Where Cells Thrive – Quantum Flex Demonstration
In just 10 minutes, you’ll experience how the Quantum Flex Cell Expansion System works and see for yourself how cells thrive, thanks to hollow-fiber perfusion technology. Quantum Flex is an automated, scalable, and functionally closed platform designed to simplify the open, labor-intensive tasks in both process development and manufacturing environments. Quantum Flex supports multiple applications, including adherent and suspension cell expansion.
Friday | June 2
10:30
Booth #01
Finish Strong – FINIA® Fill and Finish System Demonstration
You no longer have to rely on a highly manual and variable process for final formulation and the fill and finish process. In a 10-minute demo, we’ll show you how the Finia system automates mixing, cooling, air removal, aliquoting, and sealing — optimizing each step while reducing the risks associated with a manual process. Finia maintains cell viability and produces accurate and reproducible reports for suspension and adherent cells.
Don't miss our research highlights.
Poster Reception Hall
Wednesday | May 31
#206 | Reception 1
Automated Expansion of Bone Marrow-Derived MSCs on Different-Size Hollow Fiber Bioreactors
Wednesday | May 31
#409 | Reception 1
Volume Prediction Algorithm in Apheresis Hematopoietic Stem Cell Collection Improves Collection Process Efficiencies and the Patient Experience
Thursday | June 1
#826 | Reception 2
An Assessment of the Risks, Benefits, and Costs Associated with Cell Expansion and the Fill and Finish Process for Cell and Gene Therapy Manufacturers
Thursday | June 1
#879 | Reception 2
Optimized Protocol for HEK293T Cell Expansion Using the Quantum® System
Complete the Form to Register
All products may not be available in all regions. Contact your Terumo Blood and Cell Technologies representative.
It is the responsibility of the user to validate the safety and efficacy of the expanded cells for their intended application. Performance varies by user and is dependent on customer processes and materials.
Users must qualify/validate the use of the Finia system and compliance with GMP within their own manufacturing (or laboratory) environment.
This quiz was developed for entertainment purposes only. It is not intended to inform any business decisions.